These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38742248)

  • 1. Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS-HF trial.
    Vaduganathan M; Claggett BL; Lam CSP; Pitt B; Senni M; Shah SJ; Voors AA; Zannad F; Desai AS; Jhund PS; Viswanathan P; Bomfim Wirtz A; Schloemer P; Lay-Flurrie J; McMurray JJV; Solomon SD
    Eur J Heart Fail; 2024 Jun; 26(6):1324-1333. PubMed ID: 38742248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial.
    Solomon SD; Ostrominski JW; Vaduganathan M; Claggett B; Jhund PS; Desai AS; Lam CSP; Pitt B; Senni M; Shah SJ; Voors AA; Zannad F; Abidin IZ; Alcocer-Gamba MA; Atherton JJ; Bauersachs J; Ma CS; Chiang CE; Chioncel O; Chopra V; Comin-Colet J; Filippatos G; Fonseca C; Gajos G; Goland S; Goncalvesová E; Kang SM; Katova T; Kosiborod MN; Latkovskis G; Lee AP; Linssen GCM; Llamas-Esperón G; Mareev V; Martinez FA; Melenovský V; Merkely B; Nodari S; Petrie MC; Saldarriaga CI; Saraiva JFK; Sato N; Schou M; Sharma K; Troughton R; Udell JA; Ukkonen H; Vardeny O; Verma S; von Lewinski D; Voronkov LG; Yilmaz MB; Zieroth S; Lay-Flurrie J; van Gameren I; Amarante F; Viswanathan P; McMurray JJV
    Eur J Heart Fail; 2024 Jun; 26(6):1334-1346. PubMed ID: 38733212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Finerenone in Patients With a Recent Worsening Heart Failure Event: The FINEARTS-HF Trial.
    Desai AS; Vaduganathan M; Claggett BL; Kulac IJ; Jhund PS; Cunningham J; Borentain M; Lay-Flurrie J; Viswanathan P; Rohwedder K; Amarante F; Lam CSP; Senni M; Shah SJ; Voors AA; Zannad F; Pitt B; Kosiborod M; McMurray JJV; Solomon SD
    J Am Coll Cardiol; 2024 Sep; ():. PubMed ID: 39352340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease.
    Pitt B; Anker SD; Böhm M; Gheorghiade M; Køber L; Krum H; Maggioni AP; Ponikowski P; Voors AA; Zannad F; Nowack C; Kim SY; Pieper A; Kimmeskamp-Kirschbaum N; Filippatos G
    Eur J Heart Fail; 2015 Feb; 17(2):224-32. PubMed ID: 25678098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis.
    Jhund PS; Talebi A; Henderson AD; Claggett BL; Vaduganathan M; Desai AS; Lam CSP; Pitt B; Senni M; Shah SJ; Voors AA; Zannad F; Solomon SD; McMurray JJV
    Lancet; 2024 Sep; 404(10458):1119-1131. PubMed ID: 39232490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure with Mildly Reduced and Preserved Ejection Fraction: a Prespecified Analysis of The FINEARTS-HF Trial.
    Docherty KF; Henderson AD; Jhund PS; Claggett BL; Desai AS; Mueller K; Viswanathan P; Scalise A; Lam CSP; Senni M; Shah SJ; Voors AA; Zannad F; Pitt B; Vaduganathan M; Solomon SD; McMurray JJ
    Circulation; 2024 Sep; ():. PubMed ID: 39342512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated Long-Term Benefits of Finerenone in Heart Failure: A Prespecified Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial.
    Vaduganathan M; Claggett BL; Desai AS; Jhund PS; Lam CSP; Senni M; Shah SJ; Voors AA; Zannad F; Pitt B; Borentian M; Lay-Flurrie J; Viswanathan P; Behmenburg FU; McMurray JJV; Solomon SD
    JAMA Cardiol; 2024 Sep; ():. PubMed ID: 39332395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER Trial.
    Solomon SD; Vaduganathan M; Claggett BL; de Boer RA; DeMets D; Hernandez AF; Inzucchi SE; Kosiborod MN; Lam CSP; Martinez F; Shah SJ; Belohlavek J; Chiang CE; Willem Borleffs CJ; Comin-Colet J; Dobreanu D; Drozdz J; Fang JC; Alcocer Gamba MA; Al Habeeb W; Han Y; Cabrera Honorio JW; Janssens SP; Katova T; Kitakaze M; Merkely B; O'Meara E; Kerr Saraiva JF; Tereschenko SN; Thierer J; Vardeny O; Verma S; Vinh PN; Wilderäng U; Zaozerska N; Lindholm D; Petersson M; McMurray JJV
    JACC Heart Fail; 2022 Mar; 10(3):184-197. PubMed ID: 35241246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.
    Edelmann F; Wachter R; Schmidt AG; Kraigher-Krainer E; Colantonio C; Kamke W; Duvinage A; Stahrenberg R; Durstewitz K; Löffler M; Düngen HD; Tschöpe C; Herrmann-Lingen C; Halle M; Hasenfuss G; Gelbrich G; Pieske B;
    JAMA; 2013 Feb; 309(8):781-91. PubMed ID: 23443441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
    Solomon SD; McMurray JJV; Vaduganathan M; Claggett B; Jhund PS; Desai AS; Henderson AD; Lam CSP; Pitt B; Senni M; Shah SJ; Voors AA; Zannad F; Abidin IZ; Alcocer-Gamba MA; Atherton JJ; Bauersachs J; Chang-Sheng M; Chiang CE; Chioncel O; Chopra V; Comin-Colet J; Filippatos G; Fonseca C; Gajos G; Goland S; Goncalvesova E; Kang S; Katova T; Kosiborod MN; Latkovskis G; Lee AP; Linssen GCM; Llamas-Esperón G; Mareev V; Martinez FA; Melenovský V; Merkely B; Nodari S; Petrie MC; Saldarriaga CI; Saraiva JFK; Sato N; Schou M; Sharma K; Troughton R; Udell JA; Ukkonen H; Vardeny O; Verma S; von Lewinski D; Voronkov L; Yilmaz MB; Zieroth S; Lay-Flurrie J; van Gameren I; Amarante F; Kolkhof P; Viswanathan P;
    N Engl J Med; 2024 Oct; 391(16):1475-1485. PubMed ID: 39225278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease.
    Filippatos G; Anker SD; Böhm M; Gheorghiade M; Køber L; Krum H; Maggioni AP; Ponikowski P; Voors AA; Zannad F; Kim SY; Nowack C; Palombo G; Kolkhof P; Kimmeskamp-Kirschbaum N; Pieper A; Pitt B
    Eur Heart J; 2016 Jul; 37(27):2105-14. PubMed ID: 27130705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF Trial.
    Butt JH; Adamson C; Docherty KF; de Boer RA; Petrie MC; Inzucchi SE; Kosiborod MN; Maria Langkilde A; Lindholm D; Martinez FA; Bengtsson O; Schou M; O'Meara E; Ponikowski P; Sabatine MS; Sjöstrand M; Solomon SD; Jhund PS; McMurray JJV; Køber L
    Circ Heart Fail; 2021 Dec; 14(12):e008837. PubMed ID: 34802253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and Bedside.
    Kolkhof P; Jaisser F; Kim SY; Filippatos G; Nowack C; Pitt B
    Handb Exp Pharmacol; 2017; 243():271-305. PubMed ID: 27830348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF.
    Vaduganathan M; Mentz RJ; Claggett BL; Miao ZM; Kulac IJ; Ward JH; Hernandez AF; Morrow DA; Starling RC; Velazquez EJ; Williamson KM; Desai AS; Zieroth S; Lefkowitz M; McMurray JJV; Braunwald E; Solomon SD
    Eur Heart J; 2023 Aug; 44(31):2982-2993. PubMed ID: 37210743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finerenone Improves Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction Irrespective of Age: A Prespecified Analysis of FINEARTS-HF.
    Chimura M; Petrie MC; Schou M; Martinez FA; Henderson AD; Claggett BL; Desai AS; Kolkhof P; Viswanathan P; Lage A; Lam CSP; Senni M; Shah SJ; Rohwedder K; Mueller K; Voors AA; Zannad F; Pitt B; Vaduganathan M; Jhund PS; Solomon SD; McMurray JJV
    Circ Heart Fail; 2024 Nov; 17(11):e012437. PubMed ID: 39342655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction.
    Cunningham JW; Vaduganathan M; Claggett BL; Zile MR; Anand IS; Packer M; Zannad F; Lam CSP; Janssens S; Jhund PS; Kober L; Rouleau J; Shah SJ; Chopra VK; Shi VC; Lefkowitz MP; Prescott MF; Pfeffer MA; McMurray JJV; Solomon SD
    JACC Heart Fail; 2020 May; 8(5):372-381. PubMed ID: 32241619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
    Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B;
    J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy and safety of mineralocorticoid receptor antagonists in heart failure: a network meta-analysis of randomized controlled trials.
    Yang P; Shen W; Chen X; Zhu D; Xu X; Wu T; Xu G; Wu Q
    Heart Fail Rev; 2019 Sep; 24(5):637-646. PubMed ID: 31030322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the Non-Steroidal MRA Finerenone with and without Concomitant SGLT2 Inhibitor Use in Heart Failure.
    Vaduganathan M; Claggett BL; Kulac IJ; Miao ZM; Desai AS; Jhund PS; Henderson AD; Brinker M; Lay-Flurrie J; Viswanathan P; Scheerer MF; Lage A; Lam CSP; Senni M; Shah SJ; Voors AA; Zannad F; Pitt B; McMurray JJV; Solomon SD
    Circulation; 2024 Sep; ():. PubMed ID: 39340828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.